RxSight (RXST) Stock Chart & Stock Price History $8.52 +0.07 (+0.77%) As of 11:03 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock RxSight Stock Price Performance The RxSight (RXST) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 84.13%, with a year-to-date return of -75.23%. In the past month, the stock has increased 15.85%, reflecting recent market activity. As of the latest close, RxSight traded at $8.45 with a market cap of $345.74 million and volume of 1.08 million shares. Receive RXST Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RxSight and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.01%1 Month Performance+15.85%3 Month Performance-46.81%Year-To-Date Performance-75.23%1 Year Performance-84.13% RXST Stock Chart for Thursday, August, 21, 2025 RXST Chart by TradingView RxSight Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/20/2025$8.81$8.45-4.09%$8.87$8.411.08 million shs$345.74 million08/19/2025$8.49$8.81+3.77%$8.84$8.381.74 million shs$360.51 million08/18/2025$8.43$8.49+0.71%$8.83$8.311.17 million shs$347.41 million08/15/2025$8.22$8.43+2.55%$8.49$8.131.14 million shs$344.96 million08/14/2025$8.31$8.22-1.08%$8.34$8.03993,401 shs$336.33 million08/13/2025$7.35$8.31+13.06%$8.49$7.312.05 million shs$340.05 million08/12/2025$6.65$7.35+10.53%$7.45$6.731.35 million shs$300.76 million08/11/2025$7.19$6.65-7.51%$7.57$6.621.51 million shs$270.24 million08/08/2025$7.79$7.19-7.70%$7.54$6.701.66 million shs$292.18 million08/07/2025$7.55$7.79+3.18%$7.79$7.261.20 million shs$316.59 million Get the Latest News and Ratings for RXST and Related StocksEnter your email address below to receive the latest news and analysts' ratings for RxSight and its competitors with MarketBeat's FREE daily newsletter. 08/06/2025$7.65$7.55-1.31%$7.79$7.52858,224 shs$306.83 million08/05/2025$7.92$7.65-3.41%$7.96$7.641.01 million shs$310.90 million08/04/2025$7.80$7.92+1.54%$7.99$7.67757,737 shs$316.97 million08/01/2025$7.78$7.80+0.26%$7.92$7.55947,863 shs$316.97 million07/31/2025$7.98$7.78-2.51%$7.91$7.64734,468 shs$316.18 million07/30/2025$7.83$7.98+1.92%$8.31$7.75983,002 shs$324.31 million07/29/2025$7.87$7.83-0.51%$8.01$7.75887,827 shs$318.19 million07/28/2025$7.97$7.87-1.25%$8.09$7.82685,533 shs$319.84 million07/25/2025$7.94$7.97+0.38%$8.09$7.71776,343 shs$323.90 million07/24/2025$7.90$7.94+0.51%$7.98$7.70958,496 shs$322.68 million07/23/2025$7.26$7.90+8.82%$8.10$7.301.67 million shs$321.03 million07/22/2025$7.35$7.26-1.22%$7.61$7.241.35 million shs$295.05 million07/21/2025$7.35$7.35$7.82$7.351.07 million shs$298.70 million Related Companies NovoCure Stock Price Chart SS Innovations International Stock Price Chart Cadre Stock Price Chart BioLife Solutions Stock Price Chart Establishment Labs Stock Price Chart Pulse Biosciences Stock Price Chart MiMedx Group Stock Price Chart InMode Stock Price Chart iRadimed Stock Price Chart Kestra Medical Technologies Stock Price Chart Receive RXST Stock News and Ratings via EmailSign-up to receive the latest news and ratings for RxSight and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:RXST) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RxSight, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RxSight With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access